PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-205 Cr | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2025 | ₹-205 Cr |
Mar2024 | ₹-235 Cr |
Mar2023 | ₹-346 Cr |
Mar2022 | ₹-181 Cr |
Mar2021 | ₹-1,571 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-205 Cr | Negative | |
Mar2024 | ₹-235 Cr | Negative | |
Mar2023 | ₹-346 Cr | Negative | |
Mar2022 | ₹-181 Cr | Negative | |
Mar2021 | ₹-1,571 Cr | - |
Compare Cash Flow from Financing Activities of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹25,830.1 Cr | 10.3% | 5.9% | -2.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,195.0 Cr | -0.3% | -3.4% | -6.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,417.0 Cr | -1.6% | -10.2% | 30.3% | Stock Analytics | |
CIPLA | ₹124,867.0 Cr | -1% | 4.8% | -1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,971.0 Cr | 1.2% | 3.9% | 9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,956.0 Cr | -0.6% | -1.1% | -9.9% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | 10.3% |
5.9% |
-2.6% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses